From risk to resilience: a narrative overview of modifiable factors influencing anxiety in children with autism spectrum disorder (part II) - Scorecard - MDSpire
Advertisement
From risk to resilience: a narrative overview of modifiable factors influencing anxiety in children with autism spectrum disorder (part II)
Clinical Scorecard: Transforming Vulnerability into Strength: A Comprehensive Review of Alterable Factors Affecting Anxiety in Children with Autism Spectrum Disorder (Part II)
At a Glance
Category
Detail
Condition
Anxiety in Autism Spectrum Disorder (ASD)
Key Mechanisms
Sensory hypersensitivity, intolerance of uncertainty, social challenges, neurobiological vulnerability
Target Population
Children and adolescents with Autism Spectrum Disorder
Care Setting
Multidisciplinary mental health care
Key Highlights
Anxiety disorders are prevalent in children with ASD, impacting quality of life and functional impairment.
Modifiable risk factors include sensory hypersensitivity and social challenges.
Protective factors such as cognitive-behavioral therapy and structured physical activity can mitigate anxiety symptoms.
A comprehensive, multidisciplinary strategy is essential for addressing anxiety in ASD.
The study emphasizes the need for personalized approaches to mental health in children with ASD.
Guideline-Based Recommendations
Diagnosis
Early diagnosis of autism is crucial for timely intervention.
Management
Incorporate multidisciplinary, biomedical, and behavioral interventions.
Monitoring & Follow-up
Assess the impact of anxiety on functional impairment and quality of life.
Risks
Anxiety and depression frequently co-occur in children with ASD.
Patient & Prescribing Data
Children and adolescents diagnosed with Autism Spectrum Disorder
Cognitive-behavioral therapy and supportive environments are effective in reducing anxiety symptoms.
Clinical Best Practices
Utilize a comprehensive approach that integrates risk reduction and resilience-building interventions.
Focus on functional participation and emotional regulation rather than solely on symptom reduction.
From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.
